GDC-0084
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GDC-0084, covering 2016-11-02 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases [Phase 1]